OpenAlex
PricingAboutJobs
Log inGet started
Work

Golcadomide: An Oral CELMoD Agent Targeting IKZF1/3 for Diffuse Large B-cell Lymphoma

HTML

Year: 2025
Type: article
Source: Blood Cancer Discovery
DOI: 10.1158/2643-3230.bcd-25-0059
Authors: Zhongying Mo, Lynda Groocock, Scott Wood, Diana Jankeel, Derek Mendy, Edmond R. Watson, Yan Kai, Gauri Deb, Marjorie Cote, Preethi Janardhanan, Álvaro Fernández-Deudero, Leo Barnes, Sophie Peng, Matthew Groza, Evgenia Kalashnikova, Michael Angelo, Jinyi Zhu, Ryan Galasso, In Sock Jang, Manuel Sanchez Castillo, Celia Fontanillo, Geraldine Polido, Andy Christoforou, Timothy Kercher, Gabriel C. Lander, Kai Wang, Rama Krishna Narla, Soraya Carrancio, Daniel W. Pierce, Mark Rolfe, Neil Bence, Antonia Lopez-Girona
Institutions: Bristol-Myers Squibb (United States), Merck & Co., Inc., Rahway, NJ, USA (United States), Scripps Research Institute
Language: English

Topic: Protein Degradation and Inhibitors
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
SDG: Good health and well-being

Open Access status: closed

Funder: Bristol-Myers Squibb
OpenAlex ID: W4415816377
FWCI: 1.26
Cites: 55
Cited by: 5
Related to:
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms